REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Igre Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: IGRE PHARMA Gyogyszerkereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Igre Pharma Bt. is based in Hungary. The head office is in Nyiradony. The company operates in the Pharmacies and Drug Stores industry. It was established on October 01, 2003. The total number of employees is currently 8 (2024). In 2023, the company reported a net sales revenue increase of 10.87%. Its’ total assets recorded a negative growth of 0.9%. Igre Pharma Bt.’s net profit margin decreased by 2% in 2023.

Headquarters
Arpad ter 11.
Nyiradony; Hajdu-Bihar; Postal Code: 4254

Contact Details: Purchase the Igre Pharma Bt. report to view the information.

Website: http://www.nyiradonypatika.hu

Basic Information
Total Employees:
Purchase the Igre Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Igre Pharma Bt. report to view the information.
Registered Capital:
Purchase the Igre Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Igre Pharma Bt. report to view the information.
Incorporation Date:
October 01, 2003
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Igre Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.87%▲
Total operating revenue
8.72%▲
Operating profit (EBIT)
-32.21%▼
EBITDA
-19.47%▼
Net Profit (Loss) for the Period
-73.36%▼
Total assets
-0.9%▼
Total equity
-57.22%▼
Operating Profit Margin (ROS)
-1.95%▼
Net Profit Margin
-2%▼
Return on Equity (ROE)
-12.93%▼
Quick Ratio
-0.15%▼
Cash Ratio
-0.4%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo